Drawing for ALTCLIN POINTS

USPTO serial 75553027

ALTCLIN POINTS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ELSNER, KATHLEEN KEENE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALTCLIN POINTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Edward A Friedland

EDWARD A FRIEDLAND THE THOMSON INC1 STATION PLSTAMFORD, CT 06902UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer software containing a database which contains succinct summaries of clinical reviews of alternative therapies for use by healthcare professionals and alternative medicine practitionersACTIVE—
042Providing a database containing succinct summaries of clinical reviews of alternative therapies for use by healthcare professionals and alternative medicine practitioners via a global computer networkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 3, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 11, 2002EX1GSOU EXTENSION 1 GRANTED—
Mar 19, 2002MAILPAPER RECEIVED—
Mar 18, 2002EXT1SOU EXTENSION 1 FILED—
Sep 18, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 7, 2001REINREINSTATED—
Apr 20, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 20, 2000IUCNNOTICE OF ALLOWANCE CANCELLED—
Jun 20, 2000NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 28, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 25, 2000NPUBNOTICE OF PUBLICATION—
Jan 31, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 5, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance